Equities research analysts at StockNews.com assumed coverage on shares of NantHealth (NASDAQ:NH – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the stock.
NantHealth Price Performance
Shares of NASDAQ:NH opened at $0.34 on Tuesday. NantHealth has a 1-year low of $1.24 and a 1-year high of $9.75. The business has a fifty day moving average price of $0.39 and a 200-day moving average price of $0.39. The company has a market capitalization of $2.63 million, a PE ratio of -0.04 and a beta of 1.82.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. Atria Wealth Solutions Inc. boosted its position in NantHealth by 117.7% in the second quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company’s stock worth $205,000 after purchasing an additional 265,949 shares during the last quarter. Millennium Management LLC purchased a new position in NantHealth in the second quarter worth about $110,000. Goldman Sachs Group Inc. purchased a new position in NantHealth in the second quarter worth about $36,000. Finally, Susquehanna International Group LLP purchased a new position in shares of NantHealth during the 1st quarter valued at about $25,000. 4.50% of the stock is owned by hedge funds and other institutional investors.
NantHealth Company Profile
NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.
See Also
- Five stocks we like better than NantHealth
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- United Airlines Soars on Earnings Beat
- What is a Death Cross in Stocks?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Breakout Stocks: What They Are and How to Identify Them
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.